(Q46541391)

23 December 2017

title

Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker (English)

1 reference

23 December 2017

1 reference

Tobias Klatte

1

1 reference

23 December 2017

David B Seligson

2

1 reference

23 December 2017

Jian Yu Rao

3

1 reference

23 December 2017

Hong Yu

4

1 reference

23 December 2017

Michela de Martino

5

1 reference

23 December 2017

Kelly Kawaoka

6

1 reference

23 December 2017

Steven G Wong

7

1 reference

23 December 2017

Arie S Belldegrun

8

1 reference

23 December 2017

Allan J Pantuck

9

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

23 December 2017

published in

Cancer

1 reference

23 December 2017

volume

115

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

page(s)

1448-1458

1 reference

23 December 2017

Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Defining optimal therapy for muscle invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Surgical factors influence bladder cancer outcomes: a cooperative group report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

P53 as a prognostic marker for bladder cancer: a meta-analysis and review.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Tumor carbonic anhydrase 9 expression is associated with the presence of lymph node metastases in uterine cervical cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Carbonic anhydrase IX as a marker for poor prognosis in soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Expression of carbonic anhydrase 9 at the invasion front of gastric cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

The role of carbonic anhydrase IX as a molecular marker for transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Carbonic anhydrase IX expression and outcome after radiotherapy for muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

An Investigation Into the Prognostic Significance of Necrosis and Hypoxia in High Grade and Invasive Bladder Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

The natural history of bladder cancer. Implications for therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

The von Hippel-Lindau tumor suppressor protein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

[Urinary cytology in cases of bladder cancer: a critical evaluation]

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

G250: a carbonic anhydrase IX monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Cell killing by antibody-drug conjugates

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24163

7 January 2021

Identifiers

DOI

10.1002/CNCR.24163

1 reference

23 December 2017

1 reference

23 December 2017